Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelets and cytokines

S A Burstein1

  • 1University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Current Opinion in Hematology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Cytokine therapy shows promise for treating thrombocytopenia by stimulating platelet production and recovery. Further research is needed to define specific clinical uses for these thrombopoietic growth factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The blood picture in angina septica].

Mikrobiologiia·2010
Same author

Cytokines, platelet production and hemostasis.

Platelets·2010
Same author

CNS demyelination associated with copper deficiency and hyperzincemia.

Neurology·2002
Same author

Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2.

Blood·1999
Same author

Expression of a foreign protein in human megakaryocytes and platelets by retrovirally mediated gene transfer.

Experimental hematology·1999
Same author

Effects of cytokines on platelet production from blood and marrow CD34+ cells.

Blood·1998
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Thrombocytopenia, a condition of low platelet count, poses significant clinical challenges, particularly after chemotherapy.
  • Cytokines offer potential therapeutic strategies by targeting megakaryocytopoiesis, the process of platelet production.

Purpose of the Study:

  • To review the current advancements in cytokine-based therapies for ameliorating thrombocytopenia.
  • To explore the efficacy of various cytokines in promoting megakaryocytic progenitor cell proliferation and maturation.

Main Methods:

  • Review of preclinical and preliminary clinical studies on thrombopoietic cytokines.
  • Analysis of strategies involving non-lineage-specific factors, combined therapies, and mobilized peripheral blood stem cells.

Related Experiment Videos

Main Results:

  • Non-lineage-specific factors increase platelet counts post-chemotherapy.
  • Cytokines enhancing megakaryocyte maturation accelerate platelet recovery.
  • Combination therapies and novel stem cell approaches show potential for enhanced efficacy.

Conclusions:

  • Cytokine therapy represents a promising approach for managing thrombocytopenia.
  • Further investigation is required to establish precise clinical indications for thrombopoietic cytokine therapy.
  • The potential for enhancing platelet function with cytokines warrants further clinical evaluation.